RGBP Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 22:57):

Stats
Dzisiejszy wolumen	9 553.00
Średni wolumen	13 617.00
Kapitalizacja rynkowa	2.72M
EPS	$-0.0311 ( 2024-04-24 )
Następna data zysków	( $0 ) 2024-07-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.75
ATR14	$0.0110 (1.67%)

Regen BioPharma, Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Regen BioPharma, Inc. Finanse

Annual	2023
Przychody:	$236 560
Zysk brutto:	$176 560 (74.64 %)
EPS:	$0.290

FY	2023
Przychody:	$236 560
Zysk brutto:	$176 560 (74.64 %)
EPS:	$0.290

FY	2022
Przychody:	$235 517
Zysk brutto:	$185 517 (78.77 %)
EPS:	$1.750

FY	2021
Przychody:	$171 194
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.00225

Financial Reports:

No articles found.

Regen BioPharma, Inc.

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.